Icahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (58)

2024

  1. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  2. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

    Journal of Hepatology

  3. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  4. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

    Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490

  5. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

    Cell Reports, Vol. 43, Núm. 3

  6. The tip of the iceberg: a plethora of lung nodules in the general population

    The European respiratory journal

2023

  1. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

    Radiology, Vol. 309, Núm. 2, pp. e231988

  2. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  2. Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255](S0923753419317119)(10.1093/annonc/mdy308)

    Annals of Oncology

  3. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  4. Metformin keeps CD8+ T cells active and moving in NASH-HCC immunotherapy

    Journal of Hepatology

  5. New or enlarging hiatal hernias after thoracic surgery for early lung cancer

    JTCVS Open, Vol. 10, pp. 415-423

  6. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

    Gut, Vol. 71, Núm. 10, pp. 2069-2080

2021

  1. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7

  2. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 36-41

  3. Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?

    Archivos de Bronconeumologia

  4. Lung cancer risk among patients with asthma–chronic obstructive pulmonary disease overlap

    Annals of the American Thoracic Society, Vol. 18, Núm. 11, pp. 1894-1900

  5. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 9

  6. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Clinical Imaging, Vol. 78, pp. 136-141